MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study

C. Batista, M. Medeiros, C. Rieder, A. Schuh (Porto Alegre, Brazil)

Meeting: 2017 International Congress

Abstract Number: 1130

Keywords: Parkinsonism

Session Information

Date: Wednesday, June 7, 2017

Session Title: Phenomenology and Clinical Assessment Of Movement Disorders

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To correlate Parkinson’s disease (PD) subtypes with a clinical severity in a Brazilian population sample.

Background: Current studies have shown that PD may comprise different clinical subtypes. Systematic review has failed to demonstrate a single subgroup classification which may be applied across different populations (1). Therefore, the characterization of local populations help clinicians to provide better management to different patients.

Methods: Patients (N=201) from a reference center in the Southern region of Brazil (Porto Alegre) were evaluated between 2006 and 2014. After signing consent forms, all participants underwent MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), Schwab & England (SE) and Hoehn & Yahr (HY) testing. A k-means CA of UPDRS motor scores, age of onset, SE, and HY was performed. A subsequent post hoc testing (chi-square, Kruskal-Wallis, and One-Way ANOVA) was undertaken to compare the patient subgroups. Statistical analysis was conducted using IBM SPSS v.18.

Results: Hierarchical analysis identified three clusters (Table 1). The first group (N=78; 38%) was characterized by early age of onset (56±11), less severe progression (median HY = 2), and less impact on daily life activities (SE = 87 + 13). The second group (N = 70; 34.8%) was found to have later age of onset (60±11), tremor dominant, and moderate progression and impact on daily life activities (median HY = 2; SE = 75±17). The third group (N = 53; 26.4%), age of onset similar to the second  (58±11), more prevalent akinetic-rigid symptoms, and the most severe progression and impact on daily life activities (median HY = 3; SE = 46±24). All motor symptoms were statistically different among the groups (p < 0,01). The SE and HY scales were also statistically different (p < 0,001). The difference of age of onset among subgroups was not significant (p = 0,11).

Conclusions: Our findings highlight that PD does not comprise a single clinical entity.  Identifying subgroups helps predict progression and determine those patients who are likely to have more debilitating symptoms. It may also help personalize treatments to each particular set of patients.

References: 1) van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J. The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord. 2010 Jun 15;25(8):969-78.

To cite this abstract in AMA style:

C. Batista, M. Medeiros, C. Rieder, A. Schuh. Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/parkinsons-disease-subtypes-correlate-with-clinical-severity-a-brazilian-population-study/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsons-disease-subtypes-correlate-with-clinical-severity-a-brazilian-population-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley